Home/Filings/4/0001209191-23-016690
4//SEC Filing

Drape Eric 4

Accession 0001209191-23-016690

CIK 0000818686other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:05 PM ET

Size

17.9 KB

Accession

0001209191-23-016690

Insider Transaction Report

Form 4
Period: 2023-03-03
Drape Eric
Executive VP Global Operations
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+11,940123,439 total
  • Award

    Restricted Share Units

    2023-03-03+99,60199,601 total
    Ordinary Shares (99,601 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+33,512156,951 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-05+22,576179,527 total
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0411,9400 total
    Ordinary Shares (11,940 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0433,512100,536 total
    Ordinary Shares (33,512 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0522,57645,152 total
    Ordinary Shares (22,576 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
  • [F4]Restricted share units were granted on March 4, 2019, with 11,940 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023.
  • [F5]Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
  • [F6]Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022 and March 5, 2023, and 22,576 vesting on each of March 5, 2024 and March 5, 2025.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001790905

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:05 PM ET
Size
17.9 KB